Induction of chronic fos-related antigens in rat brain by chronic morphine administration

Molecular Pharmacology

Volumn 49, Issue 4, 1996, Pages 636-645

  Nye, Heather E ^a   Nestler, Eric J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MORPHINE; NALTREXONE;

ANTIGEN EXPRESSION; ARTICLE; BRAIN; CORPUS STRIATUM; DNA BINDING; DRUG DEPENDENCE; DRUG WITHDRAWAL; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; REGULATORY MECHANISM; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BLOTTING, WESTERN; BRAIN; DNA-BINDING PROTEINS; FOS-RELATED ANTIGEN-2; MALE; MORPHINE; NALTREXONE; NARCOTICS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 0029960788     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Di Chiara, G., and R. A. North. Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13:185-193 (1992).
2. Woolverton, W. L., and K. M. Johnson. Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13:193-200 (1992).
3. Wise, R. A. The role of reward pathways in the development of drug dependence, in Psychotropic Drugs of Abuse (D. J. K. Balfour, ed.). Pergamon Press, Oxford, 23-57 (1990).
4. Koob, G. F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:177-184 (1992).
5. Self, D W., and E. J. Nestler. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18:463-495 (1995).
6. Nestler, E. J., B. T. Hope, and K. W. Widnell. Drug addiction: a model for the molecular basis of neural plasticity. Neuron 11:995-1006 (1993).
7. Kalivas, P. W., and J. Stewart. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:223-244 (1991).
8. Angulo, J. A., and B. S. McEwen. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Rev. 19:1-28 (1994).
9. Sheng, M., and M. E. Greenberg. The regulation and function of c-fos and other IEGs in the nervous system. Neuron. 4:477-485 (1990).
10. Morgan, J. I., and T. Curran. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14:421-451 (1991).
11. Graybiel, A. M., R. Moratella, and H. A. Robertson. Amphetamine and cocaine-induced drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl Acad. Sci. USA 87:6912-6916 (1990).
12. Young, S. T., L. J. Porrino, and M. J. Iadarola. Cocaine induces striatal c-Fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. USA 88:1291-1295 (1991).
13. Cole, A J., R. V. Bhat, C. Patt, P. F. Worley, and J. M. Baraban D1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J. Neurochem. 58:1420-1426 (1992).
14. Hope, B. T., B. Kosofsky, S. E. Hyman, and E. J. Nestler. Regulation of IEG expression and AP-1 binding by chronic cocaine in the rat nucleus accumbens. Proc. Natl. Acad. Sci. USA 89:5764-5768 (1992).
15. Nguyen, T. V., B. E. Kosofsky, R. Birnbaum, B. M. Cohen, and S. E. Hyman. Differential expression of c-Fos and Zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl. Acad. Sci. USA 89:4270-4274 (1992).
16. Persico, A. M., C. W. Schindler, B. F. O'Hara, M. T. Brannock, and G. R. Uhl Brain transcription factor expression: effects of acute and chronic amphetamine and injection stress. Mol. Brain Res. 20:91-100 (1993).
17. Chen, J., H. E. Nye, M. B. Kelz, N. Hiroi, Y. Nakabeppu, B. Hope, and E. J. Nestler. Regulation of ΔFosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments. Mol. Pharmacol. 48:880-889 (1995).
18. Daunais, J. B., and J. F. McGinty. Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse 18:35-46 (1994).
19. Hope, B. T., H. E. Nye, M. B. Kelz, D. W. Self, M. J. Iadarola, Y. Nakabeppu, R. S. Duman, and E, J. Nestler. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13:1235-1244 (1994).
20. Hope, B. T., M. B Kelz, R. S. Duman, and E. J. Nestler. Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J. Neurosci. 14:4318-4328 (1994).
21. Chang, S. L., S. P. Squinto, and R. E. Harlan. Morphine activation of c-fos expression in rat brain. Biochem. Biophys. Res. Commun. 157:698-704 (1988).
22. Hayward, M. D., R. S. Duman, and E. J. Nestler. Induction of c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain. Brain Res. 525:256-266 (1990).
23. Liu, J., J. Nickolenko, and F. R. Sharp. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. USA 91:8537-8541 (1994).
24. Mansour, A., C. A. Fox, H. Akil, and S. J. Watson. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:22-29 (1995).
25. Di Chiara, G., M. Morelli, and S. Console. Modulatory functions of neurotransmitters in the striatum. ACh/dopamine/NMDA interactions. Trends Neurosci. 17:228-233 (1994).
26. 2 dopamine receptors. J. Pharmacol Exp. Ther. 265:53-59 (1993).
27. Spanagel, R., O. F. X Almeida, and T. S. Shippenberg. Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure. Synapse 14:243-245 (1993).
28. Blasig, J., A. Herz, K. Reinhold, and W. Zieglgansberger. Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 33:19-38 (1973).
29. Rasmussen, K., D. B. Beitner-Johnson, J. H. Krystal, G. K. Aghajanian, and E. J. Nestler. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J. Neurosci. 10: 2308-2317 (1990).
30. Guitart, X., and E. J. Nestler Identification of morphine- and cyclic AMP-regulated phosphoproteins (MARPPs) in the locus coeruleus and other regions in the rat brain: regulation by acute and chronic morphine. J. Neurosci. 9:4371-4387 (1989).
31. Acquas, E., E. Carboni, and G. Di Chiara. Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur. J Pharmacol. 193:133-134 (1991).
32. Terwilliger, R. Z., D. B. Beitner-Johnson, K. A. Sevarino, S M. Crain, and E. J. Nestler. A general role for adaptations in G-proteins and the cyclic AMP system mediating chronic actions of morphine and cocaine on neuronal function. Brain Res. 548:100-110 (1991).
33. Beitner-Johnson, D. B., X. Guitart, and E. J. Nestler. Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J. Neurosci. 12:2165-2176 (1992)
34. Sonnenberg, J. L., P. F. Macgregor-Leon, T. Curran, and J. I. Morgan. Dynamic alterations occur in the levels and composition of transcription factor AP-1 complexes after seizure. Neuron 3:359-365 (1989).
35. Miserendino, M J D., X. Guitart, R. Terwilliger, S. Chi, and E. J. Nestler. Individual differences in locomotor activity are associated with levels of tyrosine hydroxylase and neurofilament proteins in the ventral tegmental area of Sprague Dawley rats. Mol. Cell. Neurosci. 4:440-448 (1993).
36. Chieng, B., K. A. Keay, and M. J. Christie. Increased Fos-like immunoreactivity in the periaqueductal gray of anaesthetised rats during opiate withdrawal. Neurosci. Lett. 183:79-82. (1995).
37. Couceyro, P., and J. Douglass. Precipitated morphine withdrawal stimulates multiple activator protein-1 pathways in rat brain. Mol. Pharmacol 47:29-39 (1995).
38. Nye, H., B. T. Hope, M. Kelz, M. Iadarola, and E. J. Nestler. Pharmacological studies of the regulation by cocaine of chronic Fra (Fos-related antigen) induction in the striatum and nucleus accumbens. J. Pharmacol Exp. Ther. 275:1671-1680 (1995). .
39. Jian, M., W A. Staines, M. J. Iadarola, and G. S. Robertson. Destruction of the nigrostriatal pathway increases Fos-like immunoreactivity predominantly in striatopallidal neurons. Mol Brain Res. 19:156-160 (1993 ).
40. Pennypacker, K. R., L. Thai, J.-S. Hong, and M. K. McMillian. Prolonged expression of AP-1 transcription factors in the rat hippocampus after systemic kainate treatment. J. Neurosci. 14:3998-4006 (1994).
41. Winston, S. M., M. D. Hayward, E. J. Nestler, and R. S. Duman. Chronic electroeonvulsive seizures down regulate expression of the c-fos protooncogene in rat cerebral cortex. J. Neurochem. 54:1920-1925 (1990).
42. Aghajanian, G. K. Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature (Lond.) 267:186-188. (1978).
43. Koob, G. F., R. Maldonado, and L. Stimus. Neural substrates of opiate withdrawal. Trends Neurosci. 15:186-181 (1992).
44. Nestler, E. J. Molecular mechanisms of drug addiction. J. Neurosci. 12: 2439-50 (1992).
45. Kogan, J. H., E. J. Nestler, and G. K. Aghajanian. Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur. J. Pharmacol. 211:47-53 (1992).
46. Jaffe, J. H. Drug addiction and drug abuse, in Goodman and Gilman's The Pharmacological Basis of Therapeutics (T. W. Rall, A. S. Nies, and P. Taylor, eds.), Ed. 8. Pergamon Press, New York, 522-573 (1990).